Welcome to the e-CCO Library!

P346: Decreasing disparities in and use of systemic corticosteroid and disparities in use among paediatric patients with Crohn disease in a multicentre collaborative
Year: 2021
Source: ECCO'21 Virtual
Authors: Adler, J.(1);Kandavel, P.(2);Eder, S.(1);Saeed, S.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P346: Dietary practices and beliefs among parents of children with inflammatory bowel disease: preliminary results
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pituch-Zdanowska A.*1, Stawicka A.1, Jarocka-Cyrta E.2, Banaszkiewicz A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P346: Influence of diagnostic delay on ulcerative colitis characteristics at disease onset
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ramírez, C.(1);Barreiro-de Acosta, M.(2);Cabriada, J.L.(1);Rodríguez-Lago, I.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P346: Small bowel permeability improves with nutritional therapy in mild-to-moderate active paediatric Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. Wine*1, G. Abitbol2, A. Assa3, R. Sigall Boneh4, R. Shaoul5, M. Kori6, S. Cohen7, S. Peleg8, H. Shamaly9, A. On10, P. Millman11, L. Abramas4, T. Ziv Baran12, J. Van Limbergen13, A. Levine4,12

Created: Friday, 22 February 2019, 9:41 AM
P346: Soluble transferrin receptor and its relation to anaemia in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Dudkowiak*, K. Neubauer, E. Poniewierka

Created: Friday, 22 February 2019, 9:49 AM
P346: The application of indocyanine green during robotic surgery for IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.V. Marino1*, A.L. Komorowski2

Created: Thursday, 21 February 2019, 9:14 AM
P347 Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Bejar1, G. Bastida Paz1,2, M. Aguas1,2, A. Garrido Marín1, R. Marques3, E. Valero Pérez1, J. del Hoyo Francisco1, L. Tortosa Seguí1, D. Muñoz Gómez1, J.L. Poveda3, P. Nos Mateu1,2

Created: Thursday, 30 January 2020, 10:12 AM
P347: Evaluation of step up therapy in patients with early ulcerative colitis: a prospective cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bossuyt P.*1,2, Baert F.3, Coenegrachts J.-L.4, De Vos M.5, Dewit O.6, Ferrante M.7, Fontaine F.8, Mana F.9, Vandervoort J.10, Moreels T.11 Belgian IBD Research and Development Group

Created: Wednesday, 20 February 2019, 10:36 AM
P347: Identification of a cut-off for persistent anti-infliximab antibodies as a predictor of response to infliximab monotherapy
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Del Nero*1, G. Bodini2, E. Giannini2, J. Anjali3, V. Savarino1, E. Savarino4

Created: Friday, 22 February 2019, 9:49 AM
P347: New-onset autoimmune disorders, primarily psoriasis, in anti-TNF biologic exposed paediatric patients: the DEVELOP experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Veereman*1, A. Griffiths2, R. Colletti3, B. Gold4, J. Izanec5, C. Busse6, Y. Wang7, J. Escher8

Created: Friday, 22 February 2019, 9:41 AM
P347: Practical recommendations for the collection of the patient-reported outcomes included in the Health Outcomes Observatory (H2O) core data set for patients with inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fierens, L.(1)*;Casellas, F.(2);Borruel , N.(2);van der Woude , C.J.(3);Huberts, A.S.(4);Siegmund, B.(5);Sonnenberg , E.(5);Novacek , G.(6);Gerold, N.(6);Stamm , T.(7);Hedin , C.R.(8,9);Julsgaard, M.(10);Fiorino, G.(11,12);Radice, S.(13);Zini , M.L.L.(14);Gross, E.(15);Sander, C.(16);Arijs, I.(17);Vakouftsi, V.R.(18);Carney , N.(19);Charlafti , I.(20);Ferrante, M.(1,21);
Created: Friday, 14 July 2023, 11:05 AM
P347: Sarcopenia is a poor prognostic factor for endoscopic outcomes in patients with Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Grova, M.(1,2);Crispino, F.(1,2);Maida, M.(3);Vitello, A.(3);Tesè, L.(4);Rizzuto, G.(1);Casà, A.(1);Renna, S.(1);Macaluso, F.S.(1);Orlando, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P347: Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases
Year: 2021
Source: ECCO'21 Virtual
Authors: Attauabi , M.(1,2,3);Höglund , C.(4);Fassov , J.(5);Pedersen , K.B.(6);Bansholm Hansen , H.(7);Wildt , S.(8);Dam Jensen , M.(9);Neumann , A.(10);Lind , C.(10);Albæk Jacobsen , H.(11);Popa , A.M.(12);Kjeldsen , J.(13);Pedersen , N.(14);Molazahi , A.(15);Haderselv , K.(16);Aalykke , C.(4);Knudsen , T.(6);Cebula , W.(12);Munkholm, P.(7);Bendtsen , F.(1,2);Seidelin , J.B.(3);Johan , B.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P347: Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Caron1, L. Peyrin-Biroulet2, M. Nachury3, Y. Bouhnik4, P. Seksik5, G. Bouguen6, L. Caillo7, D. Laharie8, F. Carbonnel9, R. Altwegg10, C. Reenaers11, M. Serrero12, A. Boureille13, S. Nancey14, J. Filippi15, V. Abitbol1*6, G. Savoye17, L. Vuitton18, S. Viennot19, M. Fumery20, M. Reymond21, J.P. Bronowicki22, J.-M. Reimund23, A. Amiot24

Created: Thursday, 21 February 2019, 9:14 AM
P348 Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Kim1, H. Yoon2, K.M. Lee3, S.A. Jung4, D.I. Park5, C.H. Choi6, E.S. Kim7, Y. Jung8, C.S. Eun9, T.O. Kim10, S.B. Kang11, Y.S. Kim12, G.S. Seo13, C.K. Lee14, J.P. Im15, S.J. Park16, J.S. Byeon1, S.J. Myung1, S.K. Yang1, B.D. Ye1

Created: Thursday, 30 January 2020, 10:12 AM
P348: 3D reconstructions in complex fistulising perianal Crohn’s disease to aid decision-making
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Sahnan1*, S.O. Adegbola1, P.J. Tozer1, D. Burling2, A. Gupta2, J. Warusavitarne1, O.D. Faiz1, R.K. Phillips1, A.L. Hart3, P.F. Lung2

Created: Thursday, 21 February 2019, 9:14 AM
P348: Correlation between Mayo endoscopic score and validated histological score in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Shah*1, U. Dutta1, A. Das2, V. Sharma1, H. Madhavdhare1, N. Dhaka1, S. K. Sinha1, R. Kochhar1

Created: Friday, 22 February 2019, 9:41 AM
P348: Disease trajectories in ulcerative colitis: Early identification of patients with endoscopic remission at Week 52
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schreiber, S.W.(1)*;Danese, S.(2);Dirk, L.(3);Agboton, C.(4);Colombel, J.F.(5);
Created: Friday, 14 July 2023, 11:05 AM
P348: Novel model of care: the effect of a combined inflammatory bowel disease and antenatal clinic
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Selinger*1, N. Carey1, G. Ulivi2, L. Walker2, F. Shaik1, T. Glanville2

Created: Friday, 22 February 2019, 9:49 AM
P348: Perception of cancer risk in inflammatory bowel disease-associated dysplasia and management practice is influenced by colonoscopy experience and workplace affiliation: results of an international clinician survey
Year: 2021
Source: ECCO'21 Virtual
Authors: Kabir, M.(1,2);Thomas-Gibson, S.(1,2);Hart, A.(2,3);Wilson, A.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM